1. Sphingosine 1-phosphate receptor 2 promotes the onset and progression of non-alcoholic fatty liver disease-related hepatocellular carcinoma through the PI3K/AKT/mTOR pathway
   Ganggang Wang et al, 2023, Discov Onc CrossRef
2. Critical Roles of the Sphingolipid Metabolic Pathway in Liver Regeneration, Hepatocellular Carcinoma Progression and Therapy
   Hiroyuki Nojima et al, 2024, Cancers CrossRef
3. Long non-coding RNAs-Sphingolipid Metabolism Nexus: Potential Targets for Cancer Treatment
   Yan Chen et al, 2024, Pharmacological Research CrossRef